Enzo Biochem (ENZ) Reports Q4 EPS of $0.77

Enzo Biochem (NYSE: ENZ) reported Q4 EPS of $0.77, versus $0.18 reported last year. Revenue for the quarter came in at $26.6 million, versus $25.7 million reported last year.

For earnings history and earnings-related data on Enzo Biochem (ENZ) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• JPMorgan Downgrades Shenzhen Inovance Tech (300124:CH) to Neutral
• Jefferies Starts China Oilfield Services (A-Shares) (601808:CH) at Buy